Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date02 Mar 2009 |
Efficacy and tolerability of horse chestnut seed extract to improve microcirculation in diabetic patients: a placebo-controlled, randomised, double-blind, crossover, single-centre, pilot study - CES_AES_02/21
Investigation of the effectiveness, tolerability and safety of ilon® Salbe classicin the treatment of acute inflammation of the hair follicle (folliculitis) Prospective, open, evaluator-blinded, randomized, placebo-controlled multicenter trial
Investigation of the effectiveness, tolerability and safety of ilon® Salbe classic in the treatment of acute inflammation of the hair follicle (folliculitis) Prospective, open, randomized, placebo-/comparator controlled multicenter trial
100 Clinical Results associated with Cesra Arzneimittel GmbH & Co. KG
0 Patents (Medical) associated with Cesra Arzneimittel GmbH & Co. KG
100 Deals associated with Cesra Arzneimittel GmbH & Co. KG
100 Translational Medicine associated with Cesra Arzneimittel GmbH & Co. KG